Muscle carnitine deficiency in patients using valproic acid

Coulter, 1988, Prevention of hepatotoxicity recurrence with valproate monotherapy and carnitine, Ann Neurol, 24, 301 Ohtani, 1982, Carnitine deficiency and hyperammonemia associated with valproic acid therapy, J Pediatr, 101, 782, 10.1016/S0022-3476(82)80320-X Laub, 1986, Serum carnitine during valproic acid therapy, Epilepsia, 27, 559, 10.1111/j.1528-1157.1986.tb03584.x Winter, 1987, Plasma carnitine deficiency: clinical observations in 51 pediatric patients, Am J Dis Child, 141, 660, 10.1001/archpedi.1987.04460060076039 Bohles, 1982, Decreased serum carnitine in valproate-induced Reye syndrome, Eur J Pediatr, 139, 185, 10.1007/BF01377353 Glasgow, 1980, Systemic carnitine deficiency simulating recurrent Reye syndrome, J Pediatr, 96, 889, 10.1016/S0022-3476(80)80571-3 Rebouche, 1983, Carnitine metabolism and deficiency syndromes, Mayo Clin Proc, 58, 533 DiDonato, 1978, Mitochondria lipid glycogen myopathy, hyperlactacidemia and carnitine deficiency, Neurology (Minneapolis), 28, 1110, 10.1212/WNL.28.11.1110 McGarry, 1976, An improved and simplified radioisotopic assay for the determination of free and estrified carnitine, J Lipid Res, 17, 277, 10.1016/S0022-2275(20)36985-6 Borum, 1977, Muscle carnitine levels in neuromuscular disease, J Neurol Sci, 34, 279, 10.1016/0022-510X(77)90075-2 Nishida, 1987, Carnitine metabolism in valproate-treated rats: the effect of l-carnitine supplementation, Pediatr Res, 22, 500, 10.1203/00006450-198711000-00003 Engel, 1973, Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome, Science, 179, 899, 10.1126/science.179.4076.899 Dreifuss, 1987, Valproic acid hepatic fatalities: a retrospective review, Neurology, 37, 379, 10.1212/WNL.37.3.379